The Case Against Pharma Patent Monopolies | Mises Wire

Entrepreneurs face decisions in the free market for any good or service. Entrepreneurs may enter new markets, leave existing markets, or adjust the quality or price for goods offered in markets. These decisions are based on anticipation of future prices and costs.
— Read on mises.org/wire/case-against-pharma-patent-monopolies

Leave a comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.